Eli

Eli sells at-home blood-testing systems that pair a compact finger-prick collection device with CLIA-certified lab analysis; tests cover cardiovascular, thyroid, metabolic and hormone markers. Kits are sold individually ($49-$129) or via $19/month membership that includes two full panels per year and discounted add-ons, placing the brand in the mid-range tier. All ordering, results and physician-reviewed reports are handled through the company’s website; no retail distribution. The product’s core innovation is a 5-drop sample collection cartridge that stabilizes blood for up to 14 days without refrigeration, allowing USPS return shipping and eliminating the need for dried-blood spotting. Results are released in a mobile dashboard within 2 business days and include personalized ranges based on age, sex and self-reported medications. Eli positions itself as “preventive health for the rest of us,” emphasizing clinical-grade accuracy without clinic visits. Primary customers are 25-45-year-old, health-curious professionals who already track fitness metrics and want objective data to validate diet, supplement or training choices. They value convenience, transparent pricing and physician oversight but are skeptical of concierge-medicine fees; 62 % of subscribers identify as female and report using the service quarterly to monitor hormone or lipid changes. Eli competes in the direct-to-consumer diagnostics space against both finger-prick microsampling startups and traditional walk-in lab networks. It differentiates by combining medical-lab accuracy with a reusable collection device that cuts single-use plastic by 80 %, and by offering physician-reviewed, actionable reports without mandatory subscription or hidden lab fees.